14-12-2021, 05:56 PM
Hi, All:
I haven't really shared my background here on the board but I'm going to now to hopefully gain some "expert" credentials in this area. I have been in the biotech industry basically since the time it was possible to patent biotech inventions (1989). I do a significant amount of technical drafting support for companies that utilize all the sequencing technologies involved in biocodicology -- but for medical diagnosis and treatments. Since I'm in the patenting business, I learn many cutting edge techniques -- some of which I can't share because they are confidential.
The biocodicology area has moved significantly since the 2009 article cited in the general chat thread.
You are not allowed to view links. Register or Login to view.is an article from 2019 (for free) that is a better representation of the present state of the area -- although since I have done a full review of what's out there in my Voynich work I do find this review a bit optimistic, but it is a good general introduction to the techniques available.
I will say that biocodicology on the whole is behind the times significantly from what is happening in the medical world -- but that is not surprising given (1) funding challenges, (2) much lower number of labs performing this work, and (3) the understandable abhorrence of "destructive" analysis for historical objects. Obviously, none of these things are as formable of an issue when applied to medical sequencing technique development.
I'm going to add (over time -- appreciate the patience!) to this thread with reviews of significant publications in this area. In a bit of a spoiler, I will say that the results most strongly point to all the technical issues in performing and interpreting the results that have been obtained rather than providing any certain answers. But it is worthwhile exercise and one that I'd like to share with the board (at least in part to try to "pay back" all the technical help I've gotten in my Voynich research from here).
In each case, I will attempt to relate the results of the publication to possibilities for the Voynich (as that was the goal of my review -- which is complete but not in an easily shared form). Hopefully after the string of review posts are done, the board members can come away with a better understanding of what can and can't be done. But, if there is any truth in biotechnology, it continually gets better and better at solving significant nucleic acid (DNA, RNA) and protein detection problems. Thus, I have all expectations that someday these techniques will be useful to the Voynich -- but the twenty years prediction may not be far off, given the general issues above and the specific issues that will be discussed in the reviews.
The first review post to come soon.
I haven't really shared my background here on the board but I'm going to now to hopefully gain some "expert" credentials in this area. I have been in the biotech industry basically since the time it was possible to patent biotech inventions (1989). I do a significant amount of technical drafting support for companies that utilize all the sequencing technologies involved in biocodicology -- but for medical diagnosis and treatments. Since I'm in the patenting business, I learn many cutting edge techniques -- some of which I can't share because they are confidential.
The biocodicology area has moved significantly since the 2009 article cited in the general chat thread.
You are not allowed to view links. Register or Login to view.is an article from 2019 (for free) that is a better representation of the present state of the area -- although since I have done a full review of what's out there in my Voynich work I do find this review a bit optimistic, but it is a good general introduction to the techniques available.
I will say that biocodicology on the whole is behind the times significantly from what is happening in the medical world -- but that is not surprising given (1) funding challenges, (2) much lower number of labs performing this work, and (3) the understandable abhorrence of "destructive" analysis for historical objects. Obviously, none of these things are as formable of an issue when applied to medical sequencing technique development.
I'm going to add (over time -- appreciate the patience!) to this thread with reviews of significant publications in this area. In a bit of a spoiler, I will say that the results most strongly point to all the technical issues in performing and interpreting the results that have been obtained rather than providing any certain answers. But it is worthwhile exercise and one that I'd like to share with the board (at least in part to try to "pay back" all the technical help I've gotten in my Voynich research from here).
In each case, I will attempt to relate the results of the publication to possibilities for the Voynich (as that was the goal of my review -- which is complete but not in an easily shared form). Hopefully after the string of review posts are done, the board members can come away with a better understanding of what can and can't be done. But, if there is any truth in biotechnology, it continually gets better and better at solving significant nucleic acid (DNA, RNA) and protein detection problems. Thus, I have all expectations that someday these techniques will be useful to the Voynich -- but the twenty years prediction may not be far off, given the general issues above and the specific issues that will be discussed in the reviews.
The first review post to come soon.